Public Health

How Will Derek Cummings Revolutionize Infectious Disease Research?
Clinical & Pharma How Will Derek Cummings Revolutionize Infectious Disease Research?

The world of infectious disease research has seen transformative changes, and Derek Cummings is at the forefront of these innovations. As he returns to Johns Hopkins University as the Bloomberg Distinguished Professor of Infectious Disease Dynamics, his imminent contribution promises to reshape the

Can Mexico's Healthcare Reform Achieve Universal Access?
Management & Administration Can Mexico's Healthcare Reform Achieve Universal Access?

Over recent years, Mexico has embarked on an unprecedented journey to transform its public healthcare system, fostering hopes of universal access across the country. With ambitious initiatives, the government is striving to overhaul infrastructure, optimize medication procurement, and deploy

Community Paramedicine: Transforming EMS with Patient-Centered Care
Management & Administration Community Paramedicine: Transforming EMS with Patient-Centered Care

The landscape of Emergency Medical Services (EMS) has been radically transformed by the emergence of community paramedicine, a model that redefines traditional roles and practices within the industry. This approach shifts the focus from mere emergency response to a holistic, patient-centered

HPV Epidemiology in Southwest China: 2014–2024 Male Trends
Clinical & Pharma HPV Epidemiology in Southwest China: 2014–2024 Male Trends

Over an 11-year period, a rigorous study examined the molecular epidemiology of human papillomavirus (HPV) among males in the plateau region of Southwest China, illuminating essential trends and insights into public health needs. This endeavor aimed to decipher the prevalence, genotype

Embedding Health Services Research in Australian Healthcare
Clinical & Pharma Embedding Health Services Research in Australian Healthcare

Australia is grappling with a critical healthcare challenge where access to essential services lags significantly behind other nations, as underlined by its ninth-place ranking in a recent international healthcare systems report. At the core of addressing this pressing issue is the effective

How Can Canada Curb Rising Carbapenemase-Producing Infections?
Clinical & Pharma How Can Canada Curb Rising Carbapenemase-Producing Infections?

The rise of carbapenemase-producing Enterobacterales (CPE) within Canadian hospitals underscores a pressing public health challenge, aligning with global incidences of antimicrobial resistance. The exponential increase in both infection and colonization rates over the years from 2010 to 2023

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later